Combination nicotine metered dose inhaler and nicotine patch for smoking cessation: A randomized controlled trial

Nicotine and Tobacco Research

Volumn 18, Issue 10, 2016, Pages 1944-1951

  Caldwell, Brent O ^a   Crane, Julian ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINE PATCH; PLACEBO; NICOTINE GUM;

ADULT; ADVERSE DRUG REACTION; AEROSOL; AGED; ARTICLE; CONTROLLED STUDY; COUGHING; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DREAM; DRUG DOSE INCREASE; DRUG EFFICACY; FAGERSTROM TEST FOR NICOTINE DEPENDENCE; FEMALE; FOLLOW UP; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; NEW ZEALAND; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN REDNESS; SLEEP DISORDER; SMOKING CESSATION; SMOKING HABIT; TOBACCO DEPENDENCE; TRANSDERMAL PATCH; TREATMENT DURATION; TREATMENT RESPONSE; UNIVERSITY; ADOLESCENT; COMBINATION DRUG THERAPY; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PREVENTION AND CONTROL; PROCEDURES; SMOKING; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METERED DOSE INHALERS; MIDDLE AGED; NEW ZEALAND; NICOTINE; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84995571170     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntw093     Document Type: Article

References (20)

1. Institute of Medicine. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: National Academy Press;2001.
2. Schneider NG, Olmstead RE, Franzon MA, Lunell E. The nicotine inhaler clinical pharmacokinetics and comparison with other nicotine treatments. Clin Pharmacokinet. 2001;40(9):661-684. doi:10.2165/00003088-200140090-00003.
3. Caldwell B, Sumner W, Crane J. A systematic review of nicotine by inhalation: is there a role for the inhaled route? Nicotine Tob Res. 2012;14(10):1127-1139. doi:10.1093/ntr/NTS009.
4. Walton KM, Abrams DB, Bailey WC, et al. NIH electronic cigarette workshop: developing a research agenda. Nicotine Tob Res. 2014;17(2):259-269. doi:10.1093/ntr/ntu214.
5. Herxheimer A, Griffiths RL, Hamilton B, Wake M. Circulatory effects of nicotine aerosol inhalations and cigarette smoking in man. Lancet. 1967;2(7519):754-755.
6. Caldwell B, Dickson S, Burgess C, et al. A pilot study of nicotine delivery to smokers from a metered dose inhaler. Nicotine Tob Res. 2009;11(4):342-347. doi:10.1093/ntr/ntp027.
7. Andrus PG, Rhem R, Rosenfeld J, Dolovich MB. Nicotine microaerosol inhaler. Can Respir J. 1999;6(6):509-512.
8. Hansson L, Choudry NB, Karlsson JA, Fuller RW. Inhaled nicotine in humans: effect on the respiratory and cardiovascular systems. J Appl Physiol (1985). 1994;76(6):2420-2427.
9. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991;86(9):1119-1127.
10. Anonymous. Appreciative inquiry: a radically different approach to change. Healthcare Benchmarks Qual Improv. 2002;1(1):1-4.
11. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire. Addict Behav. 2007;32(5):912-923. doi:10.1016/j.addbeh.2006.06.028.
12. Cox LS, Tiffany ST, Christen AG. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob Res. 2001;3(1):7-16.
13. Cappelleri JC, Bushmakin AG, Baker CL, Merikle E, Olufade AO, Gilbert DG. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale. Curr Med Res Opin. 2005;21(5):749-760.
14. Benowitz NL, Jacob IP, Ahijevych K, et al. Biochemical verification of tobacco use and cessation. Nicotine Tob Res. 2002;4(2):149-159.
15. Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine Tob Res. 2003;5(1):13-25. doi:10.1080/1462220031000 070552.
16. West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction. 2005;100(3):299-303.
17. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013;5. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009329.pub2/abstract. Accessed March 30, 2016. doi:10.1002/14651858.CD009329.pub2.
18. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11:CD000146. doi:10.1002/14651858.CD000146.pub4.
19. Blondal T, Gudmundsson LJ, Olafsdottir I, Gustavsson G, Westin A, Stapleton J. Nicotine nasal spray with nicotine patch for smoking cessation: Randomised trial with six year follow up. BMJ. 1999;318(7179):285-289.
20. Blondal T. Correction: Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ. 1999;318:764. doi:10.1136/bmj.318.7186.764p.